Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 12825024)

Published in Am J Obstet Gynecol on June 01, 2003

Authors

Jeanette S Brown1, Leroy M Nyberg, John W Kusek, Kathryn L Burgio, Ananias C Diokno, Anders Foldspang, Nancy H Fultz, A Regula Herzog, Steinar Hunskaar, Ian Milsom, Ingrid Nygaard, Leslee L Subak, David H Thom, National Institute of Diabetes and Digestive Kidney Diseases International Research Working Group on Bladder Dysfunction

Author Affiliations

1: Department of Obstetrics/Gynecology & Reproductive Services, University of California San Francisco, 94115, USA. brownj@obgyn.ucsf.edu

Articles citing this

Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol (2006) 2.06

Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol (2014) 1.70

Diabetic bladder dysfunction: current translational knowledge. J Urol (2009) 1.51

Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care (2006) 1.50

Ventricular dilation: association with gait and cognition. Ann Neurol (2009) 1.45

Predicting improvement in urinary and bowel incontinence for home health patients using electronic health record data. J Wound Ostomy Continence Nurs (2011) 1.01

Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction. Mol Cell Proteomics (2008) 1.00

Diabetic bladder dysfunction. Chin Med J (Engl) (2014) 0.99

Physical activity and incident urinary incontinence in middle-aged women. J Urol (2008) 0.92

Diabetes related risk factors did not explain the increased risk for urinary incontinence among women with diabetes. The Norwegian HUNT/EPINCONT study. BMC Urol (2009) 0.90

A comprehensive review of urologic complications in patients with diabetes. Springerplus (2014) 0.88

Stem cells for urinary tract regeneration. Cent European J Urol (2012) 0.86

Incontinence-related quality of life and sexual function following the tension-free vaginal tape versus the "inside-out" tension-free vaginal tape obturator. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.85

Animal models of diabetic uropathy. J Urol (2009) 0.82

Urge incontinence: estimating environmental and obstetrical risk factors using an identical twin study. Int Urogynecol J (2010) 0.81

Oxybutynin extended release for the management of overactive bladder: a clinical review. Drug Des Devel Ther (2009) 0.80

Viability, differentiation capacity, and detectability of super-paramagnetic iron oxide-labeled muscle precursor cells for magnetic-resonance imaging. Tissue Eng Part C Methods (2014) 0.77

Stress urinary incontinence in women with a history of gestational diabetes mellitus. J Womens Health (Larchmt) (2008) 0.77

Management of urinary incontinence. P T (2012) 0.76

Pudendal nerve injury reduces urethral outlet resistance in diabetic rats. Am J Physiol Renal Physiol (2010) 0.76

Retracted Highlights in the minimally invasive treatment of SUI in women. J Med Life (2011) 0.75

Retracted Minimally invasive treatment for female stress urinary incontinence - Romanian highlights. J Med Life (2011) 0.75

What is the prevalence of overactive bladder symptoms in a lower socioeconomic female population?: A suggestion for a study in India. Indian J Urol (2007) 0.75

Fluid intake and risk of stress, urgency, and mixed urinary incontinence. Am J Obstet Gynecol (2011) 0.75

The dose-effect safety profile of skeletal muscle precursor cell therapy in a dog model of intrinsic urinary sphincter deficiency. Stem Cells Transl Med (2015) 0.75

Articles by these authors

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81

Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25

Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52

Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int (2003) 9.11

Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48

Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med (2010) 7.95

Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med (2007) 7.90

Prevalence of symptomatic pelvic floor disorders in US women. JAMA (2008) 7.81

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79

Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50

Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med (2006) 7.42

FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol (2006) 7.13

Urinary incontinence after vaginal delivery or cesarean section. N Engl J Med (2003) 6.32

Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA (2011) 5.86

Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol (2002) 5.73

Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med (2009) 5.58

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45

APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00

A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med (2012) 4.59

The Aging, Demographics, and Memory Study: study design and methods. Neuroepidemiology (2005) 4.44

Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (2002) 4.34

Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol (2009) 4.16

Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med (2006) 4.09

The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med (2006) 3.93

Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71

Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69

Defining success after surgery for pelvic organ prolapse. Obstet Gynecol (2009) 3.46

Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34

Differences in prevalence of urinary incontinence by race/ethnicity. J Urol (2006) 3.30

Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int (2011) 3.28

Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol (2007) 3.16

Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol (2002) 3.14

The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int (2008) 3.02

Advanced maternal age and adverse perinatal outcome. Obstet Gynecol (2004) 3.01

Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG (2003) 2.99

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol (2012) 2.96

The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med (2004) 2.94

A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med (2012) 2.90

Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86

Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82

Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. Eur Urol (2011) 2.81

The economic impact of chronic prostatitis. Arch Intern Med (2004) 2.74

Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71

Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med (2008) 2.66

The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int (2009) 2.63

Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation (2011) 2.62

Sexual activity and function in middle-aged and older women. Obstet Gynecol (2006) 2.59

Two-year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence. Obstet Gynecol (2008) 2.58

Trends in scores on tests of cognitive ability in the elderly U.S. population, 1993-2000. J Gerontol B Psychol Sci Soc Sci (2003) 2.55

Factors associated with women's decisions to seek treatment for urinary incontinence. J Womens Health (Larchmt) (2003) 2.55

Behavioral therapy with or without biofeedback and pelvic floor electrical stimulation for persistent postprostatectomy incontinence: a randomized controlled trial. JAMA (2011) 2.50

Pelvic organ prolapse surgery in the United States, 1997. Am J Obstet Gynecol (2002) 2.43

Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2012) 2.42

Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol (2008) 2.41

The rationale and design of the AASK cohort study. J Am Soc Nephrol (2003) 2.34

Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol (2009) 2.33

Effect of behavioral training with or without pelvic floor electrical stimulation on stress incontinence in women: a randomized controlled trial. JAMA (2003) 2.31

Fecal and urinary incontinence in primiparous women. Obstet Gynecol (2006) 2.28

An innovative program to train health sciences researchers to be effective clinical and translational research mentors. Acad Med (2010) 2.24

Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort. Obstet Gynecol (2007) 2.22

Validity of the incontinence severity index: comparison with pad-weighing tests. Int Urogynecol J Pelvic Floor Dysfunct (2006) 2.18

National community prevalence of overactive bladder in the United States stratified by sex and age. Urology (2011) 2.18

Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology (2009) 2.16

Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res (2003) 2.15

C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int (2005) 2.13

The impact of multimorbidity on sexual function in middle-aged and older women: beyond the single disease perspective. J Sex Med (2014) 2.12

Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis (2011) 2.11

Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol (2011) 2.09

Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc (2010) 2.03

Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. N Engl J Med (2012) 2.03

Abdominal pain, bloating, and urgency. Obstet Gynecol (2005) 2.02

Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstet Gynecol (2005) 2.01

Fecal incontinence in females older than aged 40 years: who is at risk? Dis Colon Rectum (2006) 2.01

Direct observation of requests for clinical services in office practice: what do patients want and do they get it? Arch Intern Med (2003) 2.01

Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ (2007) 1.97

Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial. Eur Urol (2012) 1.95

Postmenopausal hormone therapy: does it cause incontinence? Obstet Gynecol (2005) 1.94

Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. J Urol (2007) 1.94